UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice

Inflammatory bowel diseases, 2013-03, Vol.19 (4), p.712-719

2013

Volltextzugriff (PDF)

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

Science (American Association for the Advancement of Science), 1999-07, Vol.285 (5428), p.732-736

1999

Volltextzugriff (PDF)

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

Gut, 2010-11, Vol.59 (11), p.1485-1492

2010

Volltextzugriff (PDF)

Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2001-04, Vol.15 (4), p.463-473

2001

Volltextzugriff (PDF)

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease

Current medical research and opinion, 2013-05, Vol.29 (5), p.483-493

2013

Volltextzugriff (PDF)

Rapid and Selective Remodeling of a Positioned Nucleosome during the Induction of IL-12 p40 Transcription

Immunity (Cambridge, Mass.), 1999-12, Vol.11 (6), p.665-675

1999

Volltextzugriff (PDF)

Protein transduction: identification, characterization and optimization

Biochemical Society transactions, 2007-08, Vol.35 (Pt 4), p.811-815

2007

Volltextzugriff (PDF)

Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

Gut, 1999-04, Vol.44 (4), p.519-526

1999

Volltextzugriff (PDF)

Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins

Molecular and Cellular Biology, 1997-08, Vol.17 (8), p.4572-4588

1997

Volltextzugriff (PDF)

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

Gastroenterology (New York, N.Y. 1943), 1996-06, Vol.110 (6), p.1810-1819

1996

Volltextzugriff (PDF)

Tumor necrosis factor microsatellites define a Crohn's disease- associated haplotype on chromosome 6

Gastroenterology (New York, N.Y. 1943), 1996-04, Vol.110 (4), p.1053-1060

1996

Volltextzugriff (PDF)

A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1940-1951

2000

Volltextzugriff (PDF)

ANCA Pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in crohn's disease

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1347-1355

2001

Volltextzugriff (PDF)

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease

The Journal of immunology (1950), 1997-12, Vol.159 (12), p.6276-6282

1997

Volltextzugriff (PDF)

Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons

Neuropharmacology, 2002-06, Vol.42 (7), p.903-912

2002

Volltextzugriff (PDF)

Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach

The Journal of biological chemistry, 2001-05, Vol.276 (21), p.18519-18528

2001

Volltextzugriff (PDF)

Do serological markers and cytokines determine the indeterminate?

Journal of clinical gastroenterology, 2004-05, Vol.38 (5 Suppl 1), p.S51-S56

Plevy, Scott

2004

Volltextzugriff (PDF)

Natalizumab in complicated Crohnʼs disease: A single center experience: P-0040

Inflammatory bowel diseases, 2008-12, Vol.14, p.S22

2008

Volltextzugriff (PDF)

Natalizumab in complicated Crohnʼs disease: A single center experience

Inflammatory bowel diseases, 2008-12, Vol.14, p.S22

2008

Volltextzugriff (PDF)

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (12), p.1300-1310

2016

Volltextzugriff (PDF)

P715 Opioid use in patients with inflammatory bowel disease

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S473-S473

2018

Volltextzugriff (PDF)

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications

Diseases of the colon & rectum, 1999-05, Vol.42 (5), p.601-606

1999

Volltextzugriff (PDF)

A new syndrome of Crohn's disease and pachydermoperiostosis in a family

Gastroenterology (New York, N.Y. 1943), 1997, Vol.112 (1), p.241-249

1997

Volltextzugriff (PDF)

The immunology of inflammatory bowel disease

Gastroenterology clinics of North America, 2002-03, Vol.31 (1), p.77-92

Plevy, Scott

2002

Volltextzugriff (PDF)

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2008-10, Vol.135 (4), p.1130-1141

2008

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe American Journal Of Gastroenterology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease

Rapid and Selective Remodeling of a Positioned Nucleosome during the Induction of IL-12 p40 Transcription

Protein transduction: identification, characterization and optimization

Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

Tumor necrosis factor microsatellites define a Crohn's disease- associated haplotype on chromosome 6

A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages

ANCA Pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in crohn's disease

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease

Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons

Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach

Do serological markers and cytokines determine the indeterminate?

Natalizumab in complicated Crohnʼs disease: A single center experience: P-0040

Natalizumab in complicated Crohnʼs disease: A single center experience

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

P715 Opioid use in patients with inflammatory bowel disease

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications

A new syndrome of Crohn's disease and pachydermoperiostosis in a family

The immunology of inflammatory bowel disease

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

Aktive Filter

Suchergebnisse filtern